Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ganciclovir kinase refers to viral or cellular kinases that phosphorylate the antiviral drug ganciclovir, converting it from a prodrug into its active form. The most clinically relevant ganciclovir kinase is the UL97 protein encoded by human cytomegalovirus (HCMV), which is a serine/threonine kinase responsible for the initial phosphorylation of ganciclovir. In herpes simplex virus (HSV), thymidine kinase (TK) performs this function. Mutations in these kinases can lead to ganciclovir resistance.
Phosphorylation of ganciclovir to its monophosphate form, leading to downstream activation and inhibition of viral DNA polymerase.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ganciclovir Kinase.